OXON EPIDEMIOLOGY - Key Persons
Job Titles:
- Director of Data Analytics & HEOR
Ignacio has more than 19 years of experience in epidemiology, health economics, patient-reported outcomes and associated statistical methodologies.
He specialises in the application and analysis of PROs and health economic measures in observational studies, safety data, and benefit-risk and decision analysis. Ignacio has previously worked at the CRO, TAIS. He was a member of the ENCePP HTA task force of the EMA. He provides advanced statistical expertise.
Job Titles:
- Director of Data Management
Javier coordinates the data management activities and the design and management of OXON's Data Management System (DMS) comprising the electronic data capture tool (OXONeDC). He is responsible for building and managing the team, processes, policies, and structure and technology to deliver high quality data. He has over 20 years of experience in the Pharma industry, managing the development of Electronic Data Capture systems and project implementations. Furthermore, he has also worked in other technological areas such as health apps development and e-learning tools.
Job Titles:
- Director of Clinical Operations
Lorenzo is a medical doctor and epidemiologist with more than 20 years of experience in conducting observational studies in all major therapeutic areas in Europe.
Lorenzo previously worked as an epidemiologist at AstraZeneca and the global CRO, SGS.
Job Titles:
- Director of Pharmacovigilance
- Pharmacovigilance Director
Marta was previously head of pharmacovigilance at Schering-Plough from 1995-2010 and has experience of all areas and phases of drug safety. She has specialised in the operational, quality and compliance aspects of safety in observational studies and patient registries.
She ensures quality and compliance of all the quantitative safety projects in OXON.
Job Titles:
- Senior Clinical Epidemiologist & Director
Nawab was Director, Epidemiology and Evidence-based Medicine, GSK (1997-2005); he trained under and worked with Professor Sir Richard Peto F.R.S., and was founding editor of the Cochrane Dementia Group. He also trained in general internal medicine and geriatrics under Professor Sir John Grimley Evans and was Honorary Consultant Physician at the Radcliffe Infirmary, Oxford (1997-2000), and St's Mary's Hospital, London (2005-2006).
Job Titles:
- Director of Global Strategic Development
Steve Albrecht, has over 30 years of operational experience directing observational studies, including compassionate use. He was most recently Global Head of Late Phase for Chiltern International, based in London, UK. He has been involved in directing over 150 observational studies, including large global registries and retrospective chart studies.
He has over 500 publications, including 70+NEJM / Lancets, mainly in trials and epidemiology, and an extensive experience of data monitoring committees and EMA/FDA; devised ‘Pocock Stopping Rule', 'Win Ratio' for composite endpoints, and a new method for Individualising Benefit-Risk.
Awarded the Bradford Hill Medal in 2013 by the Royal Statistical Society, Stuart has provided OXON with advice and validation of several complex analyses over the last 7 years.